APO RESEARCH · REPORT
Marine Pharmaceuticals
The drug obtained from marine organisms which are being conventionally used like shark and cod-liver oils, sodium alginate, agar-agar, chitin etc.
Product & engineering
Understand the product.
The drug obtained from marine organisms which are being conventionally used like shark and cod-liver oils, sodium alginate, agar-agar, chitin etc.
Marine organisms are potential source for drug discovery. Life has originated from the oceans that cover over 70% of the surface of earth and contain highly ecological, chemical and biological diversity starting from micro-organisms to vertebrates. This diversity has been the source of unique chemical compounds, which hold tremendous pharmaceutical potential.
Selected research
Industry Growth & Trends
Global Marine Pharmaceuticals Industry Growth and Trends Forecast to 2032
Market perspective
The drug obtained from marine organisms which are being conventionally used like shark and cod-liver oils, sodium alginate, agar-agar, chitin etc.
Marine organisms are potential source for drug discovery. Life has originated from the oceans that cover over 70% of the surface of earth and contain highly ecological, chemical and biological diversity starting from micro-organisms to vertebrates. This diversity has been the source of unique chemical compounds, which hold tremendous pharmaceutical potential.
Global Marine Pharmaceuticals key players include Seattle Genetics, Inc., DSM, Eisai Co, Takeda, BASF, Amway, etc. Global top six manufacturers hold a share about 10%.
Read the full market overview
North America is the largest market, with a share about 35%, followed by Europe and China, both have a share over 35 percent.
In terms of product, Health Supplement is the largest segment, with a share about 90%. And in terms of application, the largest application is Pharmacy, followed by Hospital & Clinic.
Report Scope
This report provides a structured, data-driven view of the global Marine Pharmaceuticals market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Marine Pharmaceuticals market size, estimates, and forecasts are presented in terms of sales volume (M units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Marine Pharmaceuticals market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant toMarine Pharmaceuticals.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Marine Pharmaceuticals market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Marine Pharmaceuticals Market by Company
Seattle Genetics
DSM
Eisai Co
Takeda
BASF
Amway
Pfizer
Pelagia (EPAX)
Pharma Mar SA
Croda
GNC
GSK
TerSera Therapeutics
Nordic Naturals
Carlson Labs
Marine Pharmaceuticals Segment by Type
Drugs
Health Supplement
Marine Pharmaceuticals Segment by Application
Hospital & Clinic
Pharmacy
Other
Marine Pharmaceuticals Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Marine Pharmaceuticals market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Marine Pharmaceuticals and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Marine Pharmaceuticals.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Marine Pharmaceuticals manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Marine Pharmaceuticals in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Drugs
- Health Supplement
Applications
- Hospital & Clinic
- Pharmacy
- Other
Companies covered
- Seattle Genetics
- DSM
- Eisai Co
- Takeda
- BASF
- Amway
- Pfizer
- Pelagia (EPAX)
- Pharma Mar SA
- Croda
- GNC
- GSK
- TerSera Therapeutics
- Nordic Naturals
- Carlson Labs
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Marine Pharmaceuticals Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Marine Pharmaceuticals Sales Estimates and Forecasts (2021-2032)
- 1.3 Marine Pharmaceuticals Market by Type
- 1.3.1 Drugs
- 1.3.2 Health Supplement
- 1.4 Global Marine Pharmaceuticals Market Size by Type
- 1.4.1 Global Marine Pharmaceuticals Market Size Overview by Type (2021-2032)
- 1.4.2 Global Marine Pharmaceuticals Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Marine Pharmaceuticals Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Marine Pharmaceuticals Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Marine Pharmaceuticals Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Marine Pharmaceuticals Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Marine Pharmaceuticals Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Marine Pharmaceuticals Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Marine Pharmaceuticals Industry Trends
- 2.2 Marine Pharmaceuticals Industry Drivers
- 2.3 Marine Pharmaceuticals Industry Opportunities and Challenges
- 2.4 Marine Pharmaceuticals Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Marine Pharmaceuticals Revenue (2021-2026)
- 3.2 Global Top Players by Marine Pharmaceuticals Sales (2021-2026)
- 3.3 Global Top Players by Marine Pharmaceuticals Price (2021-2026)
- 3.4 Global Marine Pharmaceuticals Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Marine Pharmaceuticals Major Company Production Sites & Headquarters
- 3.6 Global Marine Pharmaceuticals Company, Product Type & Application
- 3.7 Global Marine Pharmaceuticals Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Marine Pharmaceuticals Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Marine Pharmaceuticals Players Market Share by Revenue in 2025
- 3.8.3 2025 Marine Pharmaceuticals Tier 1, Tier 2, and Tier 3
4 Marine Pharmaceuticals Regional Status and Outlook
- 4.1 Global Marine Pharmaceuticals Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Marine Pharmaceuticals Historic Market Size by Region
- 4.2.1 Global Marine Pharmaceuticals Sales in Volume by Region (2021-2026)
- 4.2.2 Global Marine Pharmaceuticals Sales in Value by Region (2021-2026)
- 4.2.3 Global Marine Pharmaceuticals Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Marine Pharmaceuticals Forecasted Market Size by Region
- 4.3.1 Global Marine Pharmaceuticals Sales in Volume by Region (2027-2032)
- 4.3.2 Global Marine Pharmaceuticals Sales in Value by Region (2027-2032)
- 4.3.3 Global Marine Pharmaceuticals Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Marine Pharmaceuticals by Application
- 5.1 Marine Pharmaceuticals Market by Application
- 5.1.1 Hospital & Clinic
- 5.1.2 Pharmacy
- 5.1.3 Other
- 5.2 Global Marine Pharmaceuticals Market Size by Application
- 5.2.1 Global Marine Pharmaceuticals Market Size Overview by Application (2021-2032)
- 5.2.2 Global Marine Pharmaceuticals Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Marine Pharmaceuticals Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Marine Pharmaceuticals Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Marine Pharmaceuticals Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Marine Pharmaceuticals Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Marine Pharmaceuticals Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Marine Pharmaceuticals Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Seattle Genetics
- 6.1.1 Seattle Genetics Company Information
- 6.1.2 Seattle Genetics Business Overview
- 6.1.3 Seattle Genetics Marine Pharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Seattle Genetics Marine Pharmaceuticals Product Portfolio
- 6.1.5 Seattle Genetics Recent Developments
- 6.2 DSM
- 6.2.1 DSM Company Information
- 6.2.2 DSM Business Overview
- 6.2.3 DSM Marine Pharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 DSM Marine Pharmaceuticals Product Portfolio
- 6.2.5 DSM Recent Developments
- 6.3 Eisai Co
- 6.3.1 Eisai Co Company Information
- 6.3.2 Eisai Co Business Overview
- 6.3.3 Eisai Co Marine Pharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Eisai Co Marine Pharmaceuticals Product Portfolio
- 6.3.5 Eisai Co Recent Developments
- 6.4 Takeda
- 6.4.1 Takeda Company Information
- 6.4.2 Takeda Business Overview
- 6.4.3 Takeda Marine Pharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Takeda Marine Pharmaceuticals Product Portfolio
- 6.4.5 Takeda Recent Developments
- 6.5 BASF
- 6.5.1 BASF Company Information
- 6.5.2 BASF Business Overview
- 6.5.3 BASF Marine Pharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 BASF Marine Pharmaceuticals Product Portfolio
- 6.5.5 BASF Recent Developments
- 6.6 Amway
- 6.6.1 Amway Company Information
- 6.6.2 Amway Business Overview
- 6.6.3 Amway Marine Pharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Amway Marine Pharmaceuticals Product Portfolio
- 6.6.5 Amway Recent Developments
- 6.7 Pfizer
- 6.7.1 Pfizer Company Information
- 6.7.2 Pfizer Business Overview
- 6.7.3 Pfizer Marine Pharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Pfizer Marine Pharmaceuticals Product Portfolio
- 6.7.5 Pfizer Recent Developments
- 6.8 Pelagia (EPAX)
- 6.8.1 Pelagia (EPAX) Company Information
- 6.8.2 Pelagia (EPAX) Business Overview
- 6.8.3 Pelagia (EPAX) Marine Pharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Pelagia (EPAX) Marine Pharmaceuticals Product Portfolio
- 6.8.5 Pelagia (EPAX) Recent Developments
- 6.9 Pharma Mar SA
- 6.9.1 Pharma Mar SA Company Information
- 6.9.2 Pharma Mar SA Business Overview
- 6.9.3 Pharma Mar SA Marine Pharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Pharma Mar SA Marine Pharmaceuticals Product Portfolio
- 6.9.5 Pharma Mar SA Recent Developments
- 6.10 Croda
- 6.10.1 Croda Company Information
- 6.10.2 Croda Business Overview
- 6.10.3 Croda Marine Pharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Croda Marine Pharmaceuticals Product Portfolio
- 6.10.5 Croda Recent Developments
- 6.11 GNC
- 6.11.1 GNC Company Information
- 6.11.2 GNC Business Overview
- 6.11.3 GNC Marine Pharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 GNC Marine Pharmaceuticals Product Portfolio
- 6.11.5 GNC Recent Developments
- 6.12 GSK
- 6.12.1 GSK Company Information
- 6.12.2 GSK Business Overview
- 6.12.3 GSK Marine Pharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 GSK Marine Pharmaceuticals Product Portfolio
- 6.12.5 GSK Recent Developments
- 6.13 TerSera Therapeutics
- 6.13.1 TerSera Therapeutics Company Information
- 6.13.2 TerSera Therapeutics Business Overview
- 6.13.3 TerSera Therapeutics Marine Pharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 TerSera Therapeutics Marine Pharmaceuticals Product Portfolio
- 6.13.5 TerSera Therapeutics Recent Developments
- 6.14 Nordic Naturals
- 6.14.1 Nordic Naturals Company Information
- 6.14.2 Nordic Naturals Business Overview
- 6.14.3 Nordic Naturals Marine Pharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 Nordic Naturals Marine Pharmaceuticals Product Portfolio
- 6.14.5 Nordic Naturals Recent Developments
- 6.15 Carlson Labs
- 6.15.1 Carlson Labs Company Information
- 6.15.2 Carlson Labs Business Overview
- 6.15.3 Carlson Labs Marine Pharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
- 6.15.4 Carlson Labs Marine Pharmaceuticals Product Portfolio
- 6.15.5 Carlson Labs Recent Developments
7 North America by Country
- 7.1 North America Marine Pharmaceuticals Sales by Country
- 7.1.1 North America Marine Pharmaceuticals Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Marine Pharmaceuticals Sales by Country (2021-2026)
- 7.1.3 North America Marine Pharmaceuticals Sales Forecast by Country (2027-2032)
- 7.2 North America Marine Pharmaceuticals Market Size by Country
- 7.2.1 North America Marine Pharmaceuticals Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Marine Pharmaceuticals Market Size by Country (2021-2026)
- 7.2.3 North America Marine Pharmaceuticals Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Marine Pharmaceuticals Sales by Country
- 8.1.1 Europe Marine Pharmaceuticals Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Marine Pharmaceuticals Sales by Country (2021-2026)
- 8.1.3 Europe Marine Pharmaceuticals Sales Forecast by Country (2027-2032)
- 8.2 Europe Marine Pharmaceuticals Market Size by Country
- 8.2.1 Europe Marine Pharmaceuticals Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Marine Pharmaceuticals Market Size by Country (2021-2026)
- 8.2.3 Europe Marine Pharmaceuticals Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Marine Pharmaceuticals Sales by Country
- 9.1.1 Asia-Pacific Marine Pharmaceuticals Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Marine Pharmaceuticals Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Marine Pharmaceuticals Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Marine Pharmaceuticals Market Size by Country
- 9.2.1 Asia-Pacific Marine Pharmaceuticals Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Marine Pharmaceuticals Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Marine Pharmaceuticals Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Marine Pharmaceuticals Sales by Country
- 10.1.1 South America Marine Pharmaceuticals Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Marine Pharmaceuticals Sales by Country (2021-2026)
- 10.1.3 South America Marine Pharmaceuticals Sales Forecast by Country (2027-2032)
- 10.2 South America Marine Pharmaceuticals Market Size by Country
- 10.2.1 South America Marine Pharmaceuticals Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Marine Pharmaceuticals Market Size by Country (2021-2026)
- 10.2.3 South America Marine Pharmaceuticals Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Marine Pharmaceuticals Sales by Country
- 11.1.1 Middle East and Africa Marine Pharmaceuticals Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Marine Pharmaceuticals Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Marine Pharmaceuticals Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Marine Pharmaceuticals Market Size by Country
- 11.2.1 Middle East and Africa Marine Pharmaceuticals Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Marine Pharmaceuticals Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Marine Pharmaceuticals Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Marine Pharmaceuticals Value Chain Analysis
- 12.1.1 Marine Pharmaceuticals Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Marine Pharmaceuticals Production Mode & Process
- 12.2 Marine Pharmaceuticals Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Marine Pharmaceuticals Distributors
- 12.2.3 Marine Pharmaceuticals Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst